Maze Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity.
The Director, Biostatistics will play a key role in shaping and supporting the clinical development of Maze's therapeutic programs. The position will oversee biostatistical strategy and execution, from study design through regulatory submissions.
Maze Therapeutics is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity.